Professional Documents
Culture Documents
Anxiety Disorders: Ashlee Hardesty, MD Interdisciplinary Case Conference August 17, 2015
Anxiety Disorders: Ashlee Hardesty, MD Interdisciplinary Case Conference August 17, 2015
Ashlee Hardesty, MD
Interdisciplinary Case Conference
August 17, 2015
Overview
Clues there may be an Anxiety Disorder
DSMV Anxiety Disorders
Treatment
Psychotherapy
Psychopharmacology
Which SSRI?
How to titrate?
Side effects?
Black box warning
Resources
31.9%
Anxiety with median age of onset of 6
years old
Anxiety had lifetime prevalence of
Common Features of
Anxiety Disorders
Anxiety is a normal human emotion
1. Intense anxiety/worry thoughts that are uncontrollable
2. Is clinically significant
Causes clinically significant distress
Impacts function
3. Associated symptoms:
Restlessness
Fatigue
Poor concentration
Muscle tension
Trouble sleeping
**Somatic symptoms
Separation Anxiety
Panic Disorder
Specific Phobia
Selective Mutism
Agoraphobia
Anxiety disorder
NOS
***PTSD/OCD used to be,
not now
Diagnostic Assessment:
Free Resources
GAD-7 SCARED
GAD-7
Over the last 2 weeks, how often have you been
bothered
by the following problems?
1. Feeling nervous, anxious, or on edge
2. Not being able to stop or control worrying
3. Worrying too much about different things
4. Trouble relaxing
5. Being so restless that it's hard to sit still
6. Becoming easily annoyed or irritable
7. Feeling afraid as if something awful might happen
If you checked off any problems, how difficult have these made it for
you to
do your work, take care of things at home, or get along with other
people?
Not difficult at all __________
Somewhat difficult _________
Very difficult _____________ Extremely difficult __________
Anxiety Disorders
Treatment
Fluoxetine
Sertraline
Escitalopram
Fluvoxamine
Often symptoms return when medication is stopped
Psychotherapy
Cognitive Behavioral Therapy
Psychopharmacology
1st line SSRI (fluoxetine, sertraline, citalopram,
escitalopram)
So which one?
Drug-drug interactions
Duration of action
Positive response to a particular SSRI by 1st degree
relative
Initial Treatment
Titrate SSRI to effective dose
After 8
Partial Improvement weeks No Improvement
Increase med to max
Reassess diagnosis
dose
Add therapy
Add therapy
adherence,
adherence,
comorbidities
comorbidities
Switch to another SSRI
Consider augmentation
Improvement
Discontinue med in 9-12 months to assess
for continued indication
Increased anxiety
Nausea
Tired/activating
Headache
Flu like symptoms
Thats It!
2 weeks later
Both Johnny and Mother report no improvement and
no observed side effects including no suicidal ideation.
Mother and Johnny agree to increase fluoxetine to
20mg today and to 30mg in two weeks.
RTC in 4 weeks.
Mother asks, How will I know if the med is working?
Johnny adds, What is the best dose for me?
4 weeks later
Johnny is on 30mg and reports taking his medications
every day.
He is feeling less anxious and is having easier time getting
hyper.
Mother agrees that he has been more irritable and has
2 weeks later
Johnny reports a worsening in symptoms.
GAD-7 score suggests less than 25% improvement.
Mother reports Johnnys grades have dropped since